Cargando…
Brand-specific enhanced safety surveillance of GSK’s Fluarix Tetra seasonal influenza vaccine in England: 2017/2018 season
In compliance with the European Medicine Agency guidance to detect any potential safety concerns associated with influenza vaccination, an enhanced safety surveillance study was conducted in England during the 2017/18 influenza season. The primary objective was to estimate the incidence rates of adv...
Autores principales: | de Lusignan, Simon, Damaso, Silvia, Ferreira, Filipa, Byford, Rachel, McGee, Christopher, Pathirannehelage, Sameera, Shende, Vishvesh, Yonova, Ivelina, Schmidt, Alexander, Schuind, Anne, Dos Santos, Gael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7482908/ https://www.ncbi.nlm.nih.gov/pubmed/32118513 http://dx.doi.org/10.1080/21645515.2019.1705112 |
Ejemplares similares
-
Enhanced Safety Surveillance of Seasonal Quadrivalent Influenza Vaccines in English Primary Care: Interim Analysis
por: de Lusignan, Simon, et al.
Publicado: (2018) -
Enhanced Safety Surveillance of GSK’s Quadrivalent Seasonal Influenza Vaccine in Belgium, Germany, and Spain for the 2018/19 Season: Interim Analysis
por: Dos Santos, Gael, et al.
Publicado: (2019) -
Brand-Specific Enhanced Safety Surveillance of GSK’s Quadrivalent Seasonal Influenza Vaccine in Belgium, Germany and Spain for the 2018/2019 Season
por: Dos Santos, Gael, et al.
Publicado: (2019) -
Passive enhanced safety surveillance of GSK’s quadrivalent seasonal influenza vaccine in Belgium, Germany and Spain, an observational study: protocol for the 2018/2019 influenza season
por: Dos Santos, Gaël, et al.
Publicado: (2019) -
Enhanced passive surveillance of influenza vaccination in England, 2016−2017– an observational study using an adverse events reporting card
por: de Lusignan, Simon, et al.
Publicado: (2019)